Organigram Holdings Inc. Shareholders Equity and Liabilities (Total)

Shareholders Equity and Liabilities (Total) of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shareholders Equity and Liabilities (Total) growth rates and interactive chart.


Highlights and Quick Summary

  • Shareholders Equity and Liabilities (Total) for the quarter ending May 31, 2022 was $459 Million (a -0.2% decrease compared to previous quarter)
  • Year-over-year quarterly Shareholders Equity and Liabilities (Total) increased by 5.11%
  • Annual Shareholders Equity and Liabilities (Total) for 2021 was $437 Million (a 34.99% increase from previous year)
  • Annual Shareholders Equity and Liabilities (Total) for 2020 was $324 Million (a 0.14% increase from previous year)
  • Annual Shareholders Equity and Liabilities (Total) for 2019 was $323 Million (a 36.42% increase from previous year)
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shareholders Equity and Liabilities (Total) of Organigram Holdings Inc.

Most recent Shareholders Equity and Liabilities (Total)of OGI including historical data for past 10 years.

Interactive Chart of Shareholders Equity and Liabilities (Total) of Organigram Holdings Inc.

Organigram Holdings Inc. Shareholders Equity and Liabilities (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $459.27 $460.18
2021 $434.17 $436.95 $460.1 $308.16 $436.95
2020 $359.53 $323.69 $310.34 $381.28 $323.69
2019 $355.12 $323.24 $319.28 $282.3 $323.24
2018 $281.78 $236.94 $236.94

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic